Martin has since learned that shingles is caused by the reactivation of the varicella zoster virus, the same virus that ...
2d
Hosted on MSNThis Vaccine Is Now Tied to a 17% Lower Dementia RiskGetting the Shingrix vaccine after the age of 50 can reduce your chances of developing the painful skin condition known as ...
While vaccine sales dropped, GSK raised its revenue guidance for 2031 with speciality medicines expected to drive that growth ...
Subsidies and existing MediSave schemes could possibly bring the out-of-pocket cost of Shingrix down to zero, says Health ...
MediSave can be used to pay for the cost of the vaccine after subsidies from 2026. Read more at straitstimes.com.
The First in China! BLA Submitted for Luzhu Biotech's Recombinant Herpes Zoster Vaccine Expected to Be Launched in 2026 HONG KONG ...
Shingrix grew 19% to £833 million in the quarter, backed up by solid performances for meningitis vaccines Bexsero and Menveo, which rose 34% to £218 million and 40% to £59 million, respectively.
India's GlaxoSmithKline Pharmaceuticals reported a higher adjusted third-quarter profit on Friday, led by sustained demand ...
Goldman Sachs downgraded Dynavax Technologies Corporation (NASDAQ:DVAX) reflecting updated views and recent competitive ...
More than 90,000 people in the Netherlands contract shingles each year, a painful viral infection that can lead to lifelong ...
Dynavax Technologies Corp (DVAX) reports record revenue for Heplisav-B, advances in vaccine programs, and strategic financial positioning despite rising R&D costs.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results